Pharmacokinetics of Intermittently Administered Intravenous Foscarnet in the Treatment of Acquired Immunodeficiency Syndrome Patients With Serious Cytomegalovirus Retinitis.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.33.5.742
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Risk of Cataract in Persons With Cytomegalovirus Retinitis and the Acquired Immune Deficiency Syndrome

Ophthalmology
Ophthalmology
2012English

Cytomegalovirus Retinitis: A Manifestation of the Acquired Immune Deficiency Syndrome (AIDS).

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1983English

Opportunistic Infections in Patients With the Acquired Immunodeficiency Syndrome

Pediatric Pathology
1990English

Brain Biopsy in Patients With Acquired Immunodeficiency Syndrome

Archives of Internal Medicine
1999English

Long-Term Suppression of Multidrug-Resistant Cytomegalovirus Retinitis With Systemically Administered Leflunomide

JAMA Ophthalmology
Ophthalmology
2013English

Drug Treatment of Toxoplasmic Encephalitis in Acquired Immunodeficiency Syndrome.

Postgraduate Medical Journal
Medicine
1995English

Treatment of Cytomegalovirus Retinitis With Zidovudine and Ganciclovir in Patients With AIDS: Outcome and Toxicity.

Sexually Transmitted Infections
DermatologyInfectious Diseases
1990English

Population Pharmacokinetics of Dapsone Administered Biweekly to Human Immunodeficiency Virus-Infected Patients.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1996English

A Survival Analysis of Hospitalization Among Patients With Acquired Immunodeficiency Syndrome.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy